Immune profiling of adipose tissue in murine models of inflammatory bowel disease (IBD) (2019) Letizia M, Sillke YR, Schmidt F, Günther C, Kunkel D, Glauben R, Siegmund B, Weidinger C Conference contribution Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histological inflammation in patients with inflammatory bowel disease (2019) Klenske E, Atreya R, Hartmann A, Fischer S, Hirschmann S, Zundler S, Iacucci M, et al. Conference contribution Point of Care detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the biosimilar SB2: performance comparison with ELISA (2019) Atreya R, Schmitt H, Fischer SM, Neurath M, Rekalde X, Nagore D, Ametzazurra A Conference contribution Frequency of B-cell subsets in infliximab-treated paediatric IBD patients (2019) Schnell A, Schwarz B, Wahlbuhl-Becker M, Allabauer I, Rechenauer T, Siebenlist G, Kaspar S, et al. Conference contribution Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease (2019) Klenske E, Osaba L, Nagore D, Rath T, Neurath M, Atreya R Journal article Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study (2018) Danese S, Neurath M, Kopon A, Zakko S, Simmons T, Fogel R, Maccarone J, et al. Conference contribution Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives (2018) De Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, et al. Journal article Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study (2018) Panaccione R, Atreya R, Ferrante M, Dubinsky MC, Sands BE, Abreu MT, Cataldi F, et al. Conference contribution Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients (2018) Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, et al. Conference contribution Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis (2018) Konturek P, Zopf Y, Dieterich W, Wirtz S, Neurath M, Brzozowski T Conference contribution